Global consistency, local relevance and controlled affiliate flexibility. Our case study explains how biopharmaceutical companies can build an MLR and MRC governance model that protects scientific and regulatory integrity across Europe while giving affiliates the room to meet local legal, medical and market requirements.
Discover key insights on:
Defining the boundaries between MLR, MRC and adjacent review pathways, including the grey zones
Separating the non-negotiable corporate core from permitted local adaptation and justified local creation
Building a European model from global principles rather than copying a global SOP
Aligning roles, decision rights, escalation routes and the content-management system with the governance model
Managing the full content lifecycle and absorbing launch pressure without losing speed or quality
